Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications

J Am Acad Dermatol. 2018 Sep;79(3):591-593. doi: 10.1016/j.jaad.2018.02.075. Epub 2018 Mar 13.

Authors

Ryan M Svoboda¹, Manish J Gharia², John Shell³, William D Gregory⁴

Affiliations

¹ National Society for Cutaneous Medicine, New York, New York. Electronic address: rmsvoboda@gmail.com.
² Madison Medical Mohs Surgery, Milwaukee, Wisconsin; Medical College of Wisconsin, Milwaukee, Wisconsin.
³ NovaScan Inc, Milwaukee, Wisconsin.
⁴ NovaScan Inc, Milwaukee, Wisconsin; College of Engineering and Applied Science, University of Wisconsin, Milwaukee, Wisconsin; College of Health Sciences, University of Wisconsin, Milwaukee, Wisconsin.

PMID: 29544743
DOI: 10.1016/j.jaad.2018.02.075

No abstract available

Publication types

Controlled Clinical Trial

MeSH terms

Carcinoma, Basal Cell / pathology
Carcinoma, Basal Cell / surgery*
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / surgery*
Disease Management
Electric Impedance*
False Negative Reactions
False Positive Reactions
Female
Frozen Sections
Humans
Male
Margins of Excision*
Mohs Surgery*
Predictive Value of Tests
Sensitivity and Specificity
Skin Neoplasms / pathology
Skin Neoplasms / surgery*